Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 39.51%
March 31, 2026 36.66%
December 31, 2025 39.39%
September 30, 2025 38.46%
June 30, 2025 37.50%
March 31, 2025 36.23%
December 31, 2024 39.22%
September 30, 2024 36.96%
June 30, 2024 37.82%
March 31, 2024 35.51%
December 31, 2023 35.64%
September 30, 2023 36.70%
June 30, 2023 35.13%
March 31, 2023 31.13%
December 31, 2022 33.10%
September 30, 2022 32.62%
June 30, 2022 34.45%
March 31, 2022 34.57%
December 31, 2021 37.82%
September 30, 2021 38.35%
June 30, 2021 39.46%
March 31, 2021 38.69%
December 31, 2020 41.75%
September 30, 2020 40.46%
June 30, 2020 40.02%
Date Value
March 31, 2020 40.73%
December 31, 2019 43.07%
September 30, 2019 41.89%
June 30, 2019 41.72%
March 31, 2019 40.03%
December 31, 2018 43.66%
September 30, 2018 41.78%
June 30, 2018 42.93%
March 31, 2018 40.62%
December 31, 2017 44.40%
September 30, 2017 42.04%
June 30, 2017 43.64%
March 31, 2017 42.02%
December 31, 2016 55.65%
September 30, 2016 55.35%
June 30, 2016 55.44%
March 31, 2016 53.67%
December 31, 2015 55.49%
September 30, 2015 53.90%
June 30, 2015 53.68%
March 31, 2015 50.73%
December 31, 2014 55.56%
September 30, 2014 53.93%
June 30, 2014 54.15%
March 31, 2014 55.81%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Kosé Holdings Corp. 69.91%
euglena Co., Ltd. 68.61%
Milbon Co., Ltd. 64.05%
Rohto Pharmaceutical Co., Ltd. 55.72%
Mandom Corp. 47.80%

Gross Profit Margin (Quarterly) Related Metrics